Caxton
Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XERS, RZLT, SPY, BRK.B, GLD, and represent 94.64% of Caxton Corp's stock portfolio.
- Added to shares of these 4 stocks: GLD, CRDF, IKT, GLYC.
- Started 4 new stock positions in GLD, IKT, CRDF, GLYC.
- Reduced shares in these 4 stocks: XERS (-$11M), ABVX, SPY, BRK.B.
- Sold out of its position in ABVX.
- Caxton Corp was a net seller of stock by $-10M.
- Caxton Corp has $17M in assets under management (AUM), dropping by -31.14%.
- Central Index Key (CIK): 0001388551
Tip: Access up to 7 years of quarterly data
Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Caxton Corp
Caxton Corp holds 15 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 41.1 | $6.8M | -60% | 2.0M | 3.39 |
|
| Rezolute Com New (RZLT) | 38.8 | $6.5M | 1.3M | 4.90 |
|
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 9.9 | $1.7M | 2.8k | 586.08 |
|
|
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 3.1 | $514k | 1.1k | 453.27 |
|
|
| Spdr Gold Tr Gold Shs (GLD) | 1.7 | $283k | NEW | 1.2k | 242.15 |
|
| Mind Medicine Mindmed Com New (MNMD) | 1.4 | $237k | 34k | 6.96 |
|
|
| Bicara Therapeutics (BCAX) | 1.1 | $191k | 11k | 17.42 |
|
|
| Lexeo Therapeutics (LXEO) | 0.7 | $118k | 18k | 6.58 |
|
|
| Kyverna Therapeutics (KYTX) | 0.5 | $86k | 23k | 3.74 |
|
|
| Compass Therapeutics (CMPX) | 0.4 | $63k | 44k | 1.45 |
|
|
| Cardiff Oncology (CRDF) | 0.3 | $58k | NEW | 13k | 4.34 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.3 | $53k | NEW | 16k | 3.25 |
|
| Glycomimetics (GLYC) | 0.3 | $51k | NEW | 204k | 0.25 |
|
| Context Therapeutics (CNTX) | 0.1 | $19k | 18k | 1.05 |
|
|
| Adicet Bio (ACET) | 0.1 | $17k | 18k | 0.96 |
|
Past Filings by Caxton Corp
SEC 13F filings are viewable for Caxton Corp going back to 2013
- Caxton Corp 2024 Q4 filed Feb. 14, 2025
- Caxton Corp 2024 Q3 filed Nov. 14, 2024
- Caxton Corp 2024 Q2 filed Aug. 14, 2024
- Caxton Corp 2024 Q1 filed May 15, 2024
- Caxton Corp 2023 Q4 filed Feb. 14, 2024
- Caxton Corp 2023 Q3 filed Nov. 14, 2023
- Caxton Corp 2023 Q2 filed Aug. 14, 2023
- Caxton Corp 2023 Q1 filed May 15, 2023
- Caxton Corp 2022 Q4 filed Feb. 14, 2023
- Caxton Corp 2022 Q3 filed Nov. 14, 2022
- Caxton Corp 2022 Q2 filed Aug. 15, 2022
- Caxton Corp 2022 Q1 filed May 16, 2022
- Caxton Corp 2021 Q4 filed Feb. 14, 2022
- Caxton Corp 2021 Q3 filed Nov. 15, 2021
- Caxton Corp 2021 Q2 filed Aug. 16, 2021
- Caxton Corp 2021 Q1 filed May 17, 2021